ANTOLRX
  • Our Vision
  • Science
  • Pipeline
  • Team
  • News
  • Careers
Select Page

Tolerogenic nanoparticles suppress central nervous system inflammation

by AnTolRx | Dec 15, 2020 | Publication

Kenison, J.E. et al. PNAS doi: 10.1073/pnas.2016451117. PMID: 33239445 (2020).

The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease.

by AnTolRx | Feb 5, 2019 | Publication

Rothhammer, V. and Quintana, F. Nat Rev Immunol. (2019)

AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.

by AnTolRx | Nov 29, 2016 | Publication

Goettel, J. et al. Cell Rep 17, 1318-1329(2016)

Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.

by AnTolRx | Aug 31, 2016 | Publication

Yeste, A. et al. Sci Signal 9, ra61(2016)

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

by AnTolRx | Aug 31, 2016 | Publication

Mascanfroni, I. D. et al. Nat Immunol 14, 1054–1063 (2013).

Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.

by AnTolRx | Aug 31, 2016 | Publication

Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L. & Quintana, F. J. Proc Natl Acad Sci USA 109, 11270–11275 (2012).
« Older Entries

News Archives

  • December 2020
  • February 2020
  • December 2019
  • November 2019
  • October 2019
  • March 2019
  • February 2019
  • January 2019
  • August 2018
  • April 2018
  • January 2018
  • November 2016
  • September 2016
  • August 2016

LOCATION

AnTolRx
One Kendall Square
Building 1400 West, Suite 14303
Cambridge, MA 02139

CONTACT

AnTolRx
info@antolrx.com
617-902-0601

  • Home
  • Our Vision
  • Science
  • Pipeline
  • News
  • Careers
  • Contact
© 2025 ANTOLRX | Website by &#10070OnyxWP